ACKR1/Duffy-null genotype testing for clozapine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).

Murtough S, Stellakis O, Mills D, Bjourson B, Chaplin V, Chauhan D, Chipp B, Cotic M, de Villiers J, Dzahini O, Elmslie F, Evans K, Gandhi S, Hughes DA, Jin H, Panconesi D, Skowronska A, Sisodiya SM, Silva E, Stinton V, Stuart-Smith S, Tarrant S, Taylor D, Varney L, Walters JTR, Wood M, Woodley J, Dello Russo C, Pirmohamed M, Bramon E

Open source

DOI: 10.1002/bcp.70576
Published: 2026 Jul
Container: British journal of clinical pharmacology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/bcp.70576,
  title = {ACKR1/Duffy-null genotype testing for clozapine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).},
  author = {Murtough S and Stellakis O and Mills D and Bjourson B and Chaplin V and Chauhan D and Chipp B and Cotic M and de Villiers J and Dzahini O and Elmslie F and Evans K and Gandhi S and Hughes DA and Jin H and Panconesi D and Skowronska A and Sisodiya SM and Silva E and Stinton V and Stuart-Smith S and Tarrant S and Taylor D and Varney L and Walters JTR and Wood M and Woodley J and Dello Russo C and Pirmohamed M and Bramon E},
  year = {2026},
  journal = {British journal of clinical pharmacology},
  doi = {10.1002/bcp.70576},
  url = {https://doi.org/10.1002/bcp.70576}
}

RIS

TY  - JOUR
TI  - ACKR1/Duffy-null genotype testing for clozapine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).
AU  - Murtough S
AU  - Stellakis O
AU  - Mills D
AU  - Bjourson B
AU  - Chaplin V
AU  - Chauhan D
AU  - Chipp B
AU  - Cotic M
AU  - de Villiers J
AU  - Dzahini O
AU  - Elmslie F
AU  - Evans K
AU  - Gandhi S
AU  - Hughes DA
AU  - Jin H
AU  - Panconesi D
AU  - Skowronska A
AU  - Sisodiya SM
AU  - Silva E
AU  - Stinton V
AU  - Stuart-Smith S
AU  - Tarrant S
AU  - Taylor D
AU  - Varney L
AU  - Walters JTR
AU  - Wood M
AU  - Woodley J
AU  - Dello Russo C
AU  - Pirmohamed M
AU  - Bramon E
PY  - 2026
JO  - British journal of clinical pharmacology
DO  - 10.1002/bcp.70576
UR  - https://doi.org/10.1002/bcp.70576
ER  -

APA

S, M., O, S., D, M., B, B., V, C., D, C., B, C., M, C., J, D. V., O, D., F, E., K, E., S, G., DA, H., H, J., D, P., A, S., SM, S., E, S., V, S., S, S., S, T., D, T., L, V., JTR, W., M, W., J, W., C, D. R., M, P., & E, B. (2026). ACKR1/Duffy-null genotype testing for clozapine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).. British journal of clinical pharmacology. https://doi.org/10.1002/bcp.70576

Source records

pubmed · retrieved 2026-09-25T14:28:08.885Z